Weekly Policy Blog: CBSA Continues Engagement on the WTO TRIPS Waiver
By: Colorado BioScience Association Date: 10/07/2022
In a few months, member states of the World Trade Organization (WTO) will decide whether to expand the TRIPS waiver to include COVID-19 therapeutics and diagnostics. Colorado BioScience Association is...
Learn MoreVictories for Innovation: Congress Reauthorizes the SBIR/STTR and User Fee Programs
By: Colorado BioScience Association Date: 09/30/2022
CBSA celebrates policy victories for Colorado's life sciences community and America’s innovators, scientists, and entrepreneurs. Congress reauthorized critical SBIR/STTR and User Fee programs. Without...
Learn MoreFitzsimons Innovation Community Companies Demonstrate Momentum
By: Colorado BioScience Association Date: 09/23/2022
Fitzsimons Innovation Community has been a partner of the Rocky Mountain Life Sciences Investor & Partnering Conference since its inception, recognizing the importance of this gathering to showcas...
Learn MoreWeekly Update: Biden Administration Cancer Moonshot Initiative; Bi-Partisan Majority Support in Congress - Multi-Cancer Early Detection Screening Coverage Act (S.1873/ H.R. 1946)
By: Colorado BioScience Association Date: 09/23/2022
President Biden’s Cancer Moonshot Initiative On the 60th anniversary of President Kennedy’s “We Choose to Go to the Moon” speech, President Biden gave an update on his Cancer Moonshot Initiative, whic...
Learn MoreCBSA Remains Active on the Critical Need to Reauthorize Vital SBIR/STTR Programs for Life Sciences
By: Colorado BioScience Association Date: 09/16/2022
Act Today and Tell Your Member of Congress to Support Vital SBIR/STTR Programs for Life Sciences The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs ar...
Learn MoreWeekly Policy Blog: Colorado BioScience Political Action Committee Fuels Policy + Advocacy Engagement and Impact
By: Colorado BioScience Association Date: 09/09/2022
The Colorado BioScience Political Action Committee (CBSA PAC), a bipartisan state political action committee, provides opportunities to educate candidates for the state legislature about our life scie...
Learn MoreColorado BioScience Association Announces Record-Breaking Attendance at Vail Investor Conference
By: Colorado BioScience Association Date: 09/06/2022
Rocky Mountain Life Sciences Investor & Partnering Conference to Welcome More than 200 Attendees Denver – Colorado BioScience Association (CBSA) will highlight the future of health innovation at t...
Learn MoreWeekly Policy Blog: August Prescription Drug Affordability Review Board (PDAB) Meeting
By: Colorado BioScience Association Date: 09/02/2022
On August 26, CBSA and our partners participated in the state Prescription Drug Affordability Review Board (PDAB) meeting, which was open to the public. The PDAB was created in 2021 when the state leg...
Learn MoreInVitria’s Technology Eliminates Risks and Protects Patients
By: Colorado BioScience Association Date: 08/29/2022
InVitria was founded with a mission to eliminate the need for blood-derived raw materials in biomanufacturing and drug formulation, primarily targeting the growing demand for human and animal serum in...
Learn MoreWeekly Policy Blog: Ethylene Oxide – Critical in Protecting Patient Health
By: Colorado BioScience Association Date: 08/26/2022
Ethylene Oxide (EtO or EO) is a colorless gas used commercially in a wide variety of ways, including the production of textiles, personal care items, and the sterilization of medical devices, cosmetic...
Learn More